GENEVA, Dec. 10 -- MIMIVAX, INC. (MRC105Elm & Carlton StreetsBuffalo, New York 14263) filed a patent application (PCT/US2025/031144) for "ANTI-SURVIVIN ANTIBODIES AND USES THEREOF" on May 28, 2025. With publication no. WO/2025/250600, the details related to the patent application was published on Dec 04, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CIESIELSKI, Michael J. (MRC 105Elm & Carlton StreetsBuffalo, New York 14263), FENSTERMAKER, Robert A. (MRC 105Elm & Carlton StreetsBuffalo, New York 14263)
Abstract: Provided herein are antibodies, and antibody fragments thereof, that bind hum...